2024 Serv. Acute STEMI (post-lecture)

B) Administering oxygen

Explanation: Administering oxygen is a common measure taken to reduce myocardial oxygen demand in patients experiencing an acute MI, as it helps improve oxygen delivery to the heart muscle.

A) Within the first 24 hours

Explanation: The occurrence of ventricular fibrillation or sustained ventricular tachycardia within the first 24 hours after a myocardial infarction typically does not require invasive electrophysiologic evaluation, as these arrhythmias are often transient and related to the acute event.

B) ST segment elevation on an ECG

Explanation: The defining feature of Acute ST Elevation Myocardial Infarction (STEMI) is the elevation of the ST segment on an electrocardiogram (ECG), indicating significant heart muscle damage due to lack of blood flow.

B) Carmine D’Amico, D.O.

Explanation: The content is attributed to Carmine D’Amico, D.O., indicating his expertise or focus on the subject of Acute ST Elevation Myocardial Infarction.

B) Coronary artery thrombosis

Explanation: The most common pathophysiologic mechanism responsible for acute myocardial infarction is coronary artery thrombosis, which leads to reduced blood flow to the heart muscle, causing ischemia and potential damage.

C) Destabilization of atherosclerotic plaque

Explanation: The most common cause of Acute Myocardial Infarction is the destabilization of atherosclerotic plaque, which leads to thrombus formation and subsequent blockage of blood flow to the heart.

D) Myocarditis

Explanation: Myocarditis is not listed as a common cause of Acute Myocardial Infarction in the provided content. The focus is on atherosclerotic plaque destabilization, embolic phenomena, and thoracic aortic dissection.

B) Embolic phenomenon

Explanation: The embolic phenomenon is specifically noted as a condition where thrombolytic therapy is contraindicated, highlighting the need for careful consideration in treatment options for Acute Myocardial Infarction.

A) Recent surgery

Explanation: Recent surgery is a contraindication for thrombolytic therapy due to the increased risk of bleeding complications, making it crucial to assess patient history before administering this treatment.

C) Elevated serum cardiac markers

Explanation: One of the key diagnostic criteria for acute myocardial infarction is the elevation of serum cardiac markers, which indicate myocardial injury and help confirm the diagnosis.

B) Thoracic aortic dissection

Explanation: Thoracic aortic dissection is mentioned as a potential cause of Acute Myocardial Infarction, indicating that a tear in the aorta can lead to complications affecting blood flow to the heart.

B) Acute Myocardial Infarction

Explanation: Chapter 7 focuses on Acute Myocardial Infarction, which is a critical condition characterized by the interruption of blood supply to the heart, leading to tissue damage.

C) 4-6 hours

Explanation: Serum cardiac markers typically begin to elevate within 4-6 hours following acute myocardial injury, which is important for timely diagnosis and management of MI.

B) They represent a spectrum of conditions related to myocardial ischemia

Explanation: Acute Coronary Syndromes encompass a range of conditions that result from reduced blood flow to the heart muscle, highlighting their critical nature in cardiovascular health.

B) ST-segment elevation myocardial infarction (STEMI)

Explanation: An indication for catheter-based intervention in acute myocardial infarction is the presence of ST-segment elevation myocardial infarction (STEMI), which requires prompt intervention to restore blood flow.

B) 171 - 199

Explanation: Chapter 7 spans pages 171 to 199, providing detailed information on Acute Coronary Syndromes and related topics.

E) Sudden weight loss

Explanation: Sudden weight loss is not a typical symptom of Acute Myocardial Infarction, whereas chest pain, shortness of breath, elevated blood pressure, and nausea are common indicators.

B) High cholesterol levels

Explanation: High cholesterol levels are a well-known risk factor for Acute Myocardial Infarction, contributing to the development of atherosclerosis and subsequent heart issues.

C) General understanding of the condition

Explanation: The overview of Acute Myocardial Infarction aims to provide a general understanding of the condition, including its significance and impact on health.

E) All of the above

Explanation: The etiology of Acute Myocardial Infarction includes various factors such as viral infections, high blood pressure, genetic predisposition, and lifestyle factors, all contributing to the risk of developing the condition.

C) Terminology used to describe heart conditions

Explanation: The nomenclature of Acute Coronary Syndromes refers to the specific terminology and classification used to describe various heart conditions, including Acute Myocardial Infarction.

B) Blood tests

Explanation: Blood tests are commonly used in the diagnosis of Acute Myocardial Infarction to detect specific biomarkers that indicate heart muscle damage.

C) To restore blood flow to the heart

Explanation: A primary goal in the management of Acute Myocardial Infarction is to restore blood flow to the heart, which is crucial for minimizing heart damage and improving patient outcomes.

D) All of the above

Explanation: Complications associated with Acute Myocardial Infarction can include stroke, heart failure, and arrhythmias, highlighting the serious nature of the condition and its potential consequences.

C) No ST segment elevation

Explanation: NSTEMI is characterized by the absence of ST segment elevation on an ECG, distinguishing it from other types of myocardial infarction.

C) It can occur without ST segment elevation

Explanation: Unstable angina is a type of acute coronary syndrome that can occur without ST segment elevation, making it distinct from other myocardial infarctions.

B) Non-Q-wave MI (NQMI)

Explanation: Most cases of Non-ST Segment Elevation Myocardial Infarction (NSTEMI) are classified as Non-Q-wave MI (NQMI), indicating the absence of Q waves on the ECG.

B) No elevation in cardiac biomarkers

Explanation: Unstable Angina is characterized by chest pain that occurs at rest or with minimal exertion, but it does not show elevation in cardiac biomarkers, distinguishing it from NSTEMI.

C) Most develop Q waves (QWMI)

Explanation: STEMI is characterized by ST segment elevation on an ECG, and most cases develop Q waves (QWMI), indicating a more severe form of myocardial infarction.

B) Few NSTEMI cases develop Q waves

Explanation: While most NSTEMI cases are classified as Non-Q-wave MI (NQMI), a few may develop Q waves, indicating a more complex presentation.

A) Non-ST Elevation Myocardial Infarction

Explanation: NSTEMI stands for Non-ST Elevation Myocardial Infarction, which indicates a type of heart attack that does not show ST elevation on an ECG but does involve elevated cardiac biomarkers.

B) ST elevation on ECG

Explanation: STEMI is characterized by ST elevation on the ECG, indicating a significant blockage of blood flow to the heart muscle, which can lead to severe damage if not treated promptly.

A) Q-wave Myocardial Infarction

Explanation: QwMI refers to Q-wave Myocardial Infarction, which indicates that there is a significant and permanent damage to the heart muscle, as evidenced by the presence of Q waves on the ECG.

B) Elevated cardiac biomarkers

Explanation: NSTEMI is distinguished from Unstable Angina by the presence of elevated cardiac biomarkers, indicating myocardial damage, while Unstable Angina does not show this elevation.

B) Type 1: Spontaneous thrombotic MI

Explanation: The classification includes Type 1 as spontaneous thrombotic myocardial infarction, which is one of the five types defined by the expert panel.

C) Type 3

Explanation: Type 3 myocardial infarction is specifically defined as sudden cardiac death with ischemic symptoms but without the presence of biomarkers.

C) Type 4

Explanation: Type 4 myocardial infarction is defined as occurring in association with percutaneous coronary intervention (PCI), highlighting its clinical context.

B) Type 2

Explanation: Type 2 myocardial infarction is classified as nonthrombotic, distinguishing it from other types that involve thrombotic events.

D) Type 5

Explanation: Type 5 myocardial infarction is specifically associated with coronary artery bypass surgery (CABG), indicating its relevance in surgical contexts.

B) To detect MI as a 'hot spot' on the nuclear scan

Explanation: The 99m Tc - pyrophosphate scan is specifically used to detect myocardial infarction (MI) by identifying a 'hot spot' on the nuclear scan, indicating areas of damage in the heart muscle between 24 hours and 5 days after symptom onset.

B) Between 24 hours and 5 days after symptom onset

Explanation: The 99m Tc - pyrophosphate scan is effective in detecting myocardial infarction within the timeframe of 24 hours to 5 days after the onset of symptoms, allowing for accurate imaging of heart damage.

C) Imaging is performed 24 hours after 111 In - antimyosin injection

Explanation: The 111 In - antimyosin scan involves imaging that is conducted 24 hours after the injection of 111 In - antimyosin, which helps in identifying areas of myocardial damage.

B) Acute myocardial infarction

Explanation: A positive scan, indicated by a 'hot spot' on the nuclear scan, may be seen in cases of acute myocardial infarction, highlighting its diagnostic significance in identifying heart conditions.

B) Unstable angina pectoris

Explanation: In addition to acute myocardial infarction, a positive 111 In-antimyosin scan can also be seen in unstable angina pectoris, indicating its utility in diagnosing various cardiac conditions.

B) Active myocarditis

Explanation: A positive 111 In-antimyosin scan may also indicate active myocarditis, showcasing its role in identifying inflammatory conditions of the heart.

A) Cardiac transplantation rejection

Explanation: A positive scan can also be seen in cases of cardiac transplantation rejection, indicating its relevance in post-transplant monitoring.

A) Symptoms, EKG, Serum cardiac markers

Explanation: The 'Big 3' components for diagnosing Acute Myocardial Infarction include symptoms, EKG readings, and serum cardiac markers, which are essential for accurate diagnosis.

D) Nuclear imaging

Explanation: Nuclear imaging techniques, while useful, are not part of the 'Big 3' for diagnosing Acute Myocardial Infarction, which focuses on symptoms, EKG, and serum cardiac markers.

C) To visualize myocardial infarction

Explanation: The Technetium-99m (99m Tc) - pyrophosphate scan is used to visualize areas of myocardial infarction, helping in the diagnosis and assessment of heart damage.

B) Antimyosin scan

Explanation: The Indium-111 (111 In) - antimyosin scan is a specific imaging technique used to diagnose heart conditions, including Acute Myocardial Infarction.

C) Myocardial scarring

Explanation: Late gadolinium enhancement CMR is used to assess myocardial scarring, which is crucial for understanding the extent of damage from an Acute Myocardial Infarction.

D) Chronic bronchitis

Explanation: Chronic bronchitis is not listed as a differential diagnosis for chest discomfort related to Acute Myocardial Infarction, while the other options are recognized conditions that can present similarly.

C) Prinzmetal’s angina

Explanation: Prinzmetal’s angina, also known as variant angina, is specifically caused by coronary artery spasm, leading to chest pain that can occur at rest.

B) Acute pericarditis

Explanation: Acute pericarditis is an inflammation of the pericardium, the outer layer of the heart, and can present with chest discomfort, making it a differential diagnosis.

C) Hypertrophic cardiomyopathy

Explanation: Hypertrophic cardiomyopathy (HCM) is characterized by an abnormal thickening of the heart muscle, which can lead to chest pain and is included in the differential diagnosis.

C) Myocardial infarction

Explanation: Myocardial infarction is a condition related to heart issues, not a pulmonary issue. The other options are all pulmonary conditions that can cause chest discomfort.

C) Thoracic aortic dissection

Explanation: Thoracic aortic dissection is a serious condition characterized by a tear in the aorta, leading to severe chest pain, and is part of the differential diagnosis for chest discomfort.

B) Pneumothorax

Explanation: Pneumothorax refers to the accumulation of air in the pleural space, which can cause chest pain and discomfort, distinguishing it from other pulmonary conditions.

B) Pneumonia

Explanation: Pneumonia is an infection that causes inflammation in the lung tissue, leading to chest discomfort, while the other options may cause discomfort through different mechanisms.

C) Pleuritis (pleurisy)

Explanation: Pleuritis, or pleurisy, is the inflammation of the pleura that can cause sharp chest pain, especially during breathing, making it a significant differential diagnosis.

B) Severe pulmonary hypertension

Explanation: Severe pulmonary hypertension refers to elevated blood pressure in the pulmonary arteries, which can lead to chest discomfort and is an important differential diagnosis.

C) Cardiovascular magnetic resonance (CMR)

Explanation: Cardiovascular magnetic resonance (CMR) is specifically mentioned as a technique used for diagnosing Acute Myocardial Infarction, highlighting its importance in the imaging process.

C) A permanent record of both acute & chronic MI

Explanation: Late gadolinium enhancement CMR is noted for revealing a permanent record of both acute and chronic myocardial infarction, making it a valuable diagnostic tool.

B) Abnormal findings

Explanation: The phrase 'Bright is abnormal' in CMR imaging indicates that bright areas on the scan are associated with abnormal findings, which is crucial for diagnosing myocardial infarction.

C) It is a newer technique

Explanation: The text specifies that CMR is a newer technique, indicating advancements in imaging technology for diagnosing myocardial infarction.

C) It is expensive

Explanation: The text mentions that CMR is an expensive technique, which can be a limitation in its widespread use for diagnosing acute myocardial infarction.

E) Pulmonary embolism

Explanation: Pulmonary embolism is a respiratory condition and not a gastrointestinal cause of chest discomfort, while the other options listed are all gastrointestinal issues that can mimic cardiac symptoms.

B) Esophagitis

Explanation: Esophagitis is the inflammation of the esophagus and is known to cause chest discomfort, making it a relevant condition in the differential diagnosis of Acute Myocardial Infarction.

E) Cholecystitis

Explanation: Cholecystitis, which is inflammation of the gallbladder, can cause biliary colic and severe abdominal pain that may be perceived as chest discomfort, making it important in the differential diagnosis.

C) Mallory-Weiss syndrome

Explanation: Mallory-Weiss syndrome involves a tear in the esophagus caused by severe vomiting, which can lead to chest discomfort and is relevant in the differential diagnosis of Acute Myocardial Infarction.

B) Gastritis

Explanation: Gastritis is the inflammation of the stomach lining and can cause symptoms that may mimic chest discomfort, making it a consideration in the differential diagnosis of Acute Myocardial Infarction.

B) Herpes zoster

Explanation: Herpes zoster is mentioned as a neurological condition that can present with chest discomfort, making it relevant in the differential diagnosis of chest pain.

B) Chest discomfort

Explanation: Intercostal neuralgia is specifically noted as a condition that can cause chest discomfort, thus it is relevant in the differential diagnosis of chest pain.

D) Myocarditis

Explanation: While neurological conditions, herpes zoster, and intercostal neuralgia are mentioned, myocarditis is not included in the provided content as part of the differential diagnosis for chest discomfort.

B) Tietze syndrome

Explanation: Tietze syndrome is specifically noted for causing tenderness and swelling of the costal cartilage, distinguishing it from other musculoskeletal conditions.

B) Costochondritis

Explanation: Costochondritis is a common differential diagnosis for chest discomfort, characterized by inflammation of the cartilage connecting the ribs to the sternum.

E) Hypertension

Explanation: Hypertension is not typically associated with chest discomfort in the context of musculoskeletal conditions, unlike the other listed conditions.

B) Myositis

Explanation: Myositis refers to inflammation of muscle tissue, which can lead to chest discomfort and is part of the differential diagnosis for such symptoms.

C) Thoracic outlet syndrome

Explanation: Thoracic outlet syndrome is characterized by pain and discomfort due to compression of nerves and blood vessels in the thoracic outlet, which can mimic cardiac-related chest pain.

A) Splenic infarction

Explanation: Splenic infarction is mentioned as part of the differential diagnosis for chest discomfort, indicating its relevance in distinguishing the cause of chest pain in patients.

A) Subdiaphragmatic abscess

Explanation: A subdiaphragmatic abscess is noted as a condition that can cause chest discomfort, highlighting its importance in the differential diagnosis process.

B) Hepatic distention

Explanation: Hepatic distention is mentioned as a condition that can be relevant in the differential diagnosis of chest discomfort, indicating its potential impact on the chest area.

B) Anxiety

Explanation: Anxiety is listed as a psychological condition that can present with chest discomfort, making it an important consideration in the differential diagnosis of acute myocardial infarction.

B) Da Costa’s syndrome

Explanation: Da Costa’s syndrome, also known as neurocirculatory asthenia, is a psychological condition that can manifest as chest discomfort, highlighting the need for differential diagnosis in acute myocardial infarction.

C) Conversion disorder

Explanation: Conversion disorder is a psychological condition where emotional distress is converted into physical symptoms, which can complicate the diagnosis of acute myocardial infarction.

B) A factitious illness

Explanation: Munchausen’s syndrome is classified as a factitious illness where individuals deliberately produce or feign symptoms, which can mimic conditions like acute myocardial infarction.

C) Hypochondriasis

Explanation: Hypochondriasis involves an excessive preoccupation with having a serious illness, which can lead to misinterpretation of symptoms and complicate the diagnosis of acute myocardial infarction.

C) Risk-benefit analysis

Explanation: In managing Acute Myocardial Infarction, it is crucial to conduct a risk-benefit analysis for every intervention, ensuring that the potential benefits outweigh the risks involved.

B) Goals and perspective

Explanation: It is important to keep the goals of treatment in mind while maintaining perspective during the management of Acute Myocardial Infarction, ensuring a holistic approach to patient care.

E) Hospital's financial status

Explanation: While managing Acute Myocardial Infarction, the focus should be on clinical considerations such as risk-benefit analysis and intervention outcomes, rather than the hospital's financial status.

B) Blockage of coronary arteries

Explanation: Acute Myocardial Infarction is primarily caused by the blockage of coronary arteries, which restricts blood flow to the heart muscle, leading to tissue damage.

B) Chest pain

Explanation: Chest pain is the most commonly recognized symptom of Acute Myocardial Infarction, often described as a feeling of pressure or squeezing in the chest.

B) Electrocardiogram (ECG)

Explanation: An Electrocardiogram (ECG) is a common diagnostic tool used to confirm Acute Myocardial Infarction by detecting changes in the heart's electrical activity.

B) Administration of aspirin

Explanation: Administration of aspirin is a common management strategy for Acute Myocardial Infarction as it helps to thin the blood and improve blood flow to the heart.

B) Blockage of coronary arteries

Explanation: Acute Myocardial Infarction is primarily caused by the blockage of coronary arteries, which restricts blood flow to the heart muscle, leading to tissue damage.

A) Stroke

Explanation: A potential complication associated with Acute Myocardial Infarction is stroke, as the same risk factors that lead to heart attacks can also increase the risk of stroke.

B) Chest pain

Explanation: Chest pain is the most commonly recognized symptom of Acute Myocardial Infarction, often described as a feeling of pressure or squeezing in the chest.

C) Electrocardiogram (ECG)

Explanation: An Electrocardiogram (ECG) is a common diagnostic tool used to confirm Acute Myocardial Infarction by detecting changes in the heart's electrical activity.

B) Administration of aspirin

Explanation: Administration of aspirin is a key management strategy for Acute Myocardial Infarction as it helps to thin the blood and improve blood flow to the heart.

B) Heart failure

Explanation: Heart failure is a potential complication associated with Acute Myocardial Infarction, as damage to the heart muscle can impair its ability to pump blood effectively.

B) Balance supply and demand of oxygen

Explanation: The primary goal in managing acute myocardial infarction is to balance the supply and demand of oxygen to the heart, ensuring that the heart muscle receives adequate oxygen to prevent further damage.

B) The oxygen delivered to the heart muscle

Explanation: In the management of acute myocardial infarction, 'supply' refers specifically to the oxygen delivered to the heart muscle, which is crucial for its survival and function during an ischemic event.

A) The heart's need for oxygen

Explanation: In the context of acute myocardial infarction management, 'demand' refers to the heart's need for oxygen, which can increase due to factors like physical activity or stress, potentially exacerbating the condition.

B) Bed rest

Explanation: Bed rest is recommended to reduce myocardial oxygen demand in patients with Acute Myocardial Infarction, helping to stabilize their condition.

B) It lyses occlusive coronary thrombus rapidly

Explanation: Thrombolytic therapy is specifically designed to rapidly dissolve occlusive coronary thrombus, which is crucial in restoring blood flow during an acute myocardial infarction.

A) Nothing by mouth

Explanation: NPO (Nil Per Os) means 'nothing by mouth,' indicating that patients should not consume food or drink until they are stable, which is crucial in managing Acute Myocardial Infarction.

C) It improves LV function

Explanation: One of the benefits of thrombolytic therapy is its ability to improve left ventricular function, which is vital for the overall recovery of the heart after an infarction.

B) Beta blockers

Explanation: Beta blockade is a key management strategy in Acute Myocardial Infarction to reduce myocardial oxygen demand, unless contraindicated.

C) It reduces both short-term and long-term mortality

Explanation: Thrombolytic therapy is beneficial as it reduces both short-term and long-term mortality rates in patients experiencing an acute myocardial infarction, making it a critical intervention.

C) Agents known to cause reflex tachycardia

Explanation: It is important to avoid agents that can cause reflex tachycardia in patients with Acute Myocardial Infarction to maintain stable heart rates and reduce myocardial oxygen demand.

B) For tachycardia associated with hypotension or CHF

Explanation: Digoxin may be of value in managing tachycardia that occurs alongside hypotension or congestive heart failure (CHF) in patients with Acute Myocardial Infarction.

D) SK

Explanation: Streptokinase (SK) is administered via IV infusion, distinguishing it from other agents that have different administration methods.

B) Single bolus

Explanation: APSAC (anistreplase) is administered as a single bolus, which is a key characteristic of its delivery method.

B) Provide supplemental oxygen

Explanation: Providing supplemental oxygen is crucial for managing myocardial oxygen supply, especially in hypoxic patients, to ensure adequate oxygenation of the heart muscle.

C) TNK-tPA

Explanation: TNK-tPA (tenecteplase) is the thrombolytic agent known as tissue plasminogen activator, which is significant in the treatment of acute myocardial infarction.

E) CABG surgery

Explanation: CABG surgery is a surgical intervention for revascularization, not a method for relieving pulmonary vascular congestion. Diuretics, IV NTG, and MSO4 are used for this purpose.

C) Double bolus, 30 minutes apart

Explanation: Reteplase (r-PA) is administered as a double bolus, with doses given 30 minutes apart, which is a specific protocol for its use.

B) Thrombolytic therapy

Explanation: In hospitals lacking primary PCI capability, thrombolytic therapy is considered the standard of care for managing acute myocardial infarction.

B) Single bolus over 5 to 10 seconds

Explanation: TNK-tPA (tenecteplase) is administered as a single bolus over a very short duration of 5 to 10 seconds, which is a rapid delivery method.

B) Bleeding

Explanation: Bleeding is a significant risk associated with thrombolytic therapy, as the treatment involves the use of medications that can disrupt normal clotting mechanisms, leading to potential hemorrhage.

C) Intra-aortic balloon pump (IABP)

Explanation: The intra-aortic balloon pump (IABP) is indicated for patients in cardiogenic shock, particularly when a catheterization lab is available, to support cardiac function.

B) To restore blood flow to the heart muscle

Explanation: Acute revascularization aims to restore blood flow to the heart muscle, which is critical in the management of myocardial infarction to minimize damage to the heart.

B) Anaphylaxis

Explanation: Anaphylaxis is a serious allergic reaction that can occur with thrombolytic agents such as SK and APSAC, highlighting the importance of monitoring patients for adverse reactions during treatment.

B) Arrhythmia

Explanation: Arrhythmia can occur as a reperfusion complication during thrombolytic therapy, as restoring blood flow to the heart can lead to electrical instability in the myocardium.

B) Hypotension

Explanation: Hypotension is a potential risk of thrombolytic therapy, as the medications can cause a decrease in blood pressure, which may require careful monitoring and management.

B) ST segment elevation > 1 mm in 2 or more contiguous leads

Explanation: ST segment elevation greater than 1 mm in two or more contiguous precordial or limb leads is a key criterion for diagnosing acute myocardial infarction, indicating significant myocardial injury.

C) New (or presumed new) LBBB

Explanation: The presence of a new or presumed new left bundle branch block (LBBB) is a significant EKG change that can indicate acute myocardial infarction, warranting further evaluation.

B) < 6 hours

Explanation: Thrombolytic therapy is most beneficial when administered within 6 hours of symptom onset in acute myocardial infarction, as this time frame maximizes the chances of restoring blood flow and minimizing heart damage.

B) ST segment depression with prominent R waves in leads V1 and V2

Explanation: ST segment depression with prominent R waves in leads V1 and V2 can suggest a posterior wall infarction, especially if it is differentiated from unstable angina.

C) Less beneficial but still worthwhile

Explanation: Administering thrombolytic therapy between 6 to 12 hours after symptom onset is considered less beneficial but can still provide worthwhile outcomes in certain cases.

B) Little apparent benefit unless ongoing symptoms

Explanation: If thrombolytic therapy is administered more than 12 hours after symptom onset, it generally shows little apparent benefit unless there is ongoing chest discomfort or a 'stuttering' course of symptoms.

C) Any chronological age

Explanation: There is no age restriction for the use of thrombolytic therapy in acute myocardial infarction; it can be administered to patients of any chronological age.

C) First, do no harm

Explanation: The principle of 'First, do no harm' emphasizes the importance of ensuring patient safety before administering thrombolytic therapy, highlighting the need for careful assessment.

C) Administer a second medication

Explanation: Administering a second medication is not listed as a necessary step before thrombolytic therapy; instead, obtaining a medical history, examining the patient, and checking vital signs are crucial.

D) All of the above

Explanation: Before administering thrombolytic therapy, it is essential to obtain a medical history, examine the patient, and conduct assessments including vitals, chest radiograph, EKG, and lab work.

B) Complete blood count and coagulation profile

Explanation: Before thrombolytic therapy, lab work typically includes a complete blood count and coagulation profile to assess the patient's readiness for treatment and to minimize risks.

B) To assess for contraindications

Explanation: Examining the patient before thrombolytic therapy is crucial to assess for any contraindications that may pose risks during treatment, ensuring patient safety.

B) Risk : benefit ratio

Explanation: When considering thrombolytic therapy, it is crucial to evaluate the risk versus benefit ratio to ensure that the potential advantages outweigh the risks involved in the treatment.

B) Suspected aortic dissection

Explanation: Suspected aortic dissection is specifically listed as a contraindication for thrombolytic therapy, as it poses significant risks during treatment.

C) It is standard of care

Explanation: Thrombolytic therapy is regarded as the standard of care in situations where a primary PCI-designated cath lab is not readily available, highlighting its importance in the management of Acute Myocardial Infarction.

B) Active bleeding or bleeding diathesis (excluding menses)

Explanation: Active bleeding or a bleeding diathesis, except for menstrual bleeding, is a contraindication for thrombolytic therapy due to the increased risk of severe complications.

B) Reason for not giving therapy

Explanation: If thrombolytic therapy is not provided, it is essential to document the reason for this decision, ensuring clarity and accountability in patient care.

B) Few

Explanation: There are few absolute contraindications for thrombolytic therapy, which allows for its broader application in treating Acute Myocardial Infarction when appropriate.

B) Known structural cerebral vascular lesion

Explanation: A known structural cerebral vascular lesion, such as an arteriovenous malformation, is a contraindication for thrombolytic therapy due to the increased risk of hemorrhage.

B) Ischemic stroke within 3 months

Explanation: An ischemic stroke within the last 3 months is a contraindication for thrombolytic therapy, except if it is an acute ischemic stroke occurring within 3 hours.

C) Catheter-based intervention

Explanation: Catheter-based intervention is identified as the revascularization strategy of choice for acute STEMI, highlighting its effectiveness in restoring blood flow during this critical condition.

D) Acute ischemic stroke within 3 hours

Explanation: Acute ischemic stroke within 3 hours is not a contraindication for thrombolytic therapy; in fact, it may be an indication for treatment.

B) In STEMI complicated by cardiogenic shock

Explanation: Primary PCI is noted to be especially superior to thrombolytic therapy in cases of STEMI complicated by cardiogenic shock, indicating its critical role in high-risk scenarios.

B) Significant closed-head or facial trauma within 3 months

Explanation: Significant closed-head or facial trauma within the last 3 months is a contraindication for thrombolytic therapy due to the risk of bleeding.

B) Patients with CAD not amenable to catheter-based revascularization

Explanation: CABG surgery is indicated for patients with coronary artery disease (CAD) that cannot be treated effectively with catheter-based revascularization, making it a crucial option for certain patients.

B) Known malignant intracranial neoplasm

Explanation: A known malignant intracranial neoplasm, whether primary or metastatic, is a significant risk factor that contraindicates the use of thrombolytic therapy due to the potential for increased bleeding.

B) Patients with acute MI

Explanation: CABG surgery is indicated for patients with mechanical complications arising from acute myocardial infarction (MI), emphasizing its role in addressing severe complications following an MI.

B) The effectiveness of primary PCI vs. thrombolytic therapy

Explanation: The studies aim to compare the effectiveness of primary percutaneous coronary intervention (PCI) with thrombolytic therapy (TT) for acute myocardial infarction (AMI), highlighting the importance of treatment options.

B) Primary Percutaneous Coronary Intervention (PCI)

Explanation: Primary Percutaneous Coronary Intervention (PCI) is the primary treatment method being compared to thrombolytic therapy for managing Acute Myocardial Infarction (AMI), highlighting its significance in revascularization strategies.

C) 7,739

Explanation: The analysis included a total of 7,739 patients, providing a substantial sample size for evaluating the outcomes of the two treatment methods.

B) The effectiveness of PCI versus thrombolytic therapy for AMI

Explanation: The referenced studies focus on comparing the effectiveness of Primary Percutaneous Coronary Intervention (PCI) and thrombolytic therapy for treating Acute Myocardial Infarction (AMI), indicating their relevance in clinical decision-making.

B) 1990 - 2003

Explanation: The studies included in the analysis were conducted over a time span from 1990 to 2003, indicating the period during which the data was collected.

C) Coronary Artery Bypass Grafting

Explanation: The content specifically discusses Primary Percutaneous Coronary Intervention (PCI) and thrombolytic therapy (TT) for Acute Myocardial Infarction (AMI), but does not mention Coronary Artery Bypass Grafting as a treatment option.

C) 4-6 weeks

Explanation: Short-term outcomes are defined as occurring within 4 to 6 weeks, which is a critical period for assessing the immediate effectiveness of treatments for AMI.

C) A quantitative review

Explanation: The study by Keeley et al. is described as a quantitative review of 23 randomized trials, indicating a statistical approach to comparing the two treatment methods for AMI.

D) 6-18 months

Explanation: Long-term outcomes are defined as occurring within 6 to 18 months, allowing for the evaluation of the sustained effectiveness and safety of the treatments over a longer period.

D) Lancet

Explanation: The study comparing primary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction was published in the Lancet, a well-known medical journal.

B) Lidocaine

Explanation: Lidocaine is specifically mentioned as a medication to avoid in the management of Acute Myocardial Infarction unless there is a clear-cut indication, highlighting its limited use in this context.

A) IV magnesium

Explanation: IV magnesium is also listed as a medication to avoid in the treatment of Acute Myocardial Infarction unless there is a clear-cut indication, indicating its cautious use.

B) ASA (Aspirin)

Explanation: ASA (Aspirin) is a standard adjunctive medical therapy used in the management of Acute Myocardial Infarction to help prevent further clot formation.

B) It is a P2Y12 inhibitor that prevents platelet aggregation

Explanation: Clopidogrel is a P2Y12 inhibitor that plays a crucial role in preventing platelet aggregation, thereby reducing the risk of further clot formation during an Acute Myocardial Infarction.

B) If the patient is hypoxic

Explanation: Supplemental oxygen is indicated in the management of Acute Myocardial Infarction specifically when the patient is hypoxic, to ensure adequate oxygenation of tissues.

B) MSO4 (Morphine)

Explanation: MSO4, or Morphine, is an opioid analgesic that is used in the management of Acute Myocardial Infarction to relieve pain and anxiety.

B) Unfractionated and low molecular weight

Explanation: Heparin can be classified as both unfractionated and low molecular weight, and it is commonly used in the management of Acute Myocardial Infarction to prevent thrombus formation.

C) Abciximab

Explanation: Abciximab is a glycoprotein IIb/IIIa inhibitor that is utilized in adjunctive medical therapy for Acute Myocardial Infarction, helping to prevent platelet aggregation.

B) It reduces myocardial oxygen demand

Explanation: IV nitroglycerin is used to reduce myocardial oxygen demand by causing vasodilation, which helps alleviate chest pain and improve blood flow during an Acute Myocardial Infarction.

C) In right ventricular infarctions

Explanation: β-blockers should be avoided in cases of right ventricular infarctions as they can worsen hemodynamic stability and lead to complications.

A) Lisinopril

Explanation: Lisinopril is a commonly used ACE inhibitor that helps to reduce mortality and improve outcomes in patients following an Acute Myocardial Infarction.

C) To reduce cholesterol levels

Explanation: Statins are primarily used to lower cholesterol levels, which can help reduce the risk of future cardiovascular events in patients who have experienced an Acute Myocardial Infarction.

C) Echocardiography

Explanation: Most mechanical complications following an Acute Myocardial Infarction can be diagnosed using echocardiography, provided there is sufficient time for the procedure.

C) IABP insertion followed by emergent open-heart surgery

Explanation: The standard treatment for most mechanical complications involves the insertion of an Intra-Aortic Balloon Pump (IABP) followed by emergent open-heart surgery.

B) 3 to 5 days

Explanation: The peak incidence of most mechanical complications typically occurs 3 to 5 days after an Acute Myocardial Infarction, indicating a critical period for monitoring and intervention.

C) Ventricular free wall rupture

Explanation: Ventricular free wall rupture is classified as a mechanical complication of Acute Myocardial Infarction, highlighting the structural damage that can occur to the heart muscle following an infarction.

B) Electrical

Explanation: Tachyarrhythmia is categorized as an electrical complication of Acute Myocardial Infarction, indicating disturbances in the heart's electrical conduction system that can occur after an infarction.

C) Ventricular septal rupture

Explanation: Ventricular septal rupture is a specific complication of Acute Myocardial Infarction that involves a rupture in the wall separating the left and right ventricles, leading to significant hemodynamic instability.

C) Pulmonary congestion

Explanation: Acute mitral regurgitation can lead to pulmonary congestion due to the backflow of blood into the left atrium, which can occur as a complication of Acute Myocardial Infarction.

B) Ventricular pseudoaneurysm

Explanation: A ventricular pseudoaneurysm is characterized by a false aneurysm formation in the ventricle, which can occur after an Acute Myocardial Infarction and poses a risk of rupture.

B) Tachyarrhythmia

Explanation: Tachyarrhythmia is identified as a common electrical complication following an Acute Myocardial Infarction, highlighting the potential for abnormal heart rhythms in this condition.

E) No EPS indicated

Explanation: Generally, an electrophysiological study (EPS) is not indicated if ventricular tachycardia or ventricular fibrillation occurs within 48 hours of an acute myocardial infarction, indicating a cautious approach to management during this critical period.

B) Electrical cardioversion

Explanation: For unstable patients experiencing atrial fibrillation or atrial flutter following an acute myocardial infarction, electrical cardioversion is recommended to restore normal heart rhythm.

B) Control ventricular rate

Explanation: In stable patients with atrial fibrillation after an acute myocardial infarction, the primary goal of medical therapy is to control the ventricular rate using medications such as beta-blockers or digoxin.

B) Beta-blockers and digoxin

Explanation: Beta-blockers and digoxin are commonly used to control the ventricular rate in patients with atrial fibrillation following an acute myocardial infarction, along with anticoagulation to prevent thromboembolic events.

B) Bradyarrhythmia

Explanation: Bradyarrhythmia is a type of electrical complication that can occur during an Acute Myocardial Infarction, indicating a slower than normal heart rate.

A) Observation only

Explanation: In some cases, observation may be sufficient for managing bradyarrhythmia, especially if the patient is stable and asymptomatic.

A) Atropine

Explanation: Atropine is a medication that can be used to increase heart rate in cases of symptomatic bradyarrhythmia during an Acute Myocardial Infarction.

C) Temporary pacemaker (external or transvenous)

Explanation: A temporary pacemaker can be used to manage severe bradyarrhythmia until a more permanent solution is determined.

D) Anticoagulants

Explanation: Anticoagulants are not a treatment option for bradyarrhythmia; they are typically used to prevent blood clots, not to manage heart rate issues.

B) To make the correct diagnosis

Explanation: The summary emphasizes the importance of making the correct diagnosis as the primary goal in managing Acute Myocardial Infarction, which is crucial for effective treatment.

C) Perspective on the patient's condition

Explanation: The summary highlights the need to always maintain perspective, suggesting that understanding the patient's overall condition is vital in managing Acute Myocardial Infarction effectively.

B) A basic fundamental strategy

Explanation: The summary advises using a basic fundamental strategy to guide therapy rather than a 'cookbook' approach, emphasizing the need for tailored treatment based on individual patient needs.

B) The risk: benefit ratio

Explanation: The summary stresses the importance of considering the risk: benefit ratio for each intervention, whether medical or non-medical, to ensure that the benefits outweigh the risks involved.

C) Complications

Explanation: The summary indicates that healthcare providers should anticipate complications, highlighting the need for vigilance and preparedness in managing potential adverse events during treatment.

B) Ventricular thrombus formation

Explanation: Ventricular thrombus formation is a significant complication that can occur after an Acute Myocardial Infarction, leading to subsequent embolization, which can cause further complications.

B) Cardiogenic shock

Explanation: Cardiogenic shock is a critical complication of Acute Myocardial Infarction that results from the heart's inability to pump effectively, leading to a severe drop in blood pressure and inadequate perfusion of organs.

C) A late form of pericarditis

Explanation: Dressler syndrome is a late complication of Acute Myocardial Infarction characterized by pericarditis that occurs weeks to months after the initial event, often due to an autoimmune response.